Aveanna Q2 revenue up 13.7% to $670.5M; raises FY2026 guidance

Aveanna Healthcare Holdings, Inc.

2026-Q2 EPS reported $0.37 revenue$1,318,398,000

Q2 revenue $670.5M (+13.7% YoY); net income $40.3M vs $27.0M; diluted EPS $0.18 vs $0.13.
Adjusted EBITDA $95.4M (+8.0% YoY); adjusted EPS $0.22 vs $0.18.
FY2026 revenue guidance raised to >$2.68B (from $2.63-2.65B); Adjusted EBITDA >$365M (from $338-342M).
Segment revenue growth: PDS +$67.9M, HHH +$8.9M, MS +$4.1M; gross margin fell to 32.6% from 35.8%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.